V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014701 | 260010085 | 1.65 | 83.3 | Palliative (P) | 2018-12-22 | 2018-12-22 | Vinblastine | 02 | N | 260011488 | IFOSFAMIDE + PACLITAXEL |
| 260014702 | 260010086 | 1.64 | 75.6 | null | 2018-11-30 | 2019-05-25 | Cytarabine HD + Methotrexate HD | N | N | 260011489 | NIVOLUMAB |
| 260014703 | 260010086 | 1.57 | 46.2 | Palliative (P) | 2018-03-10 | 2018-03-10 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260011489 | LIPOSOMAL DOXORUBICIN |
| 260014704 | 260010087 | 1.58 | null | Palliative (P) | 2017-02-08 | 2017-02-15 | BLEOMYCIN + VINCRISTINE | 02 | N | 260011685 | BLEOMYCIN + VINCRISTINE |
| 260014705 | 260010087 | 1.73 | 102 | Palliative (P) | 2015-07-26 | 2015-07-28 | VIP | N | N | 260011685 | IFOSFAMIDE + PACLITAXEL |
| 260014706 | 260018243 | 1.71 | 77 | Palliative (P) | 2018-12-06 | 2018-12-13 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | 2 | N | 260011792 | CARBOPLATIN + VINORELBINE |
| 260014707 | 260018243 | 1.84 | null | Palliative (P) | 2017-08-21 | 2017-08-21 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 260011792 | RMS 2005 TRIAL |
| 260014708 | 260018243 | 1.67 | 102 | Curative (C) | 2015-12-25 | 2016-01-02 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 2 | N | 260011792 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014709 | 260018243 | 1.74 | 64 | Neo-adjuvant (N) | 2018-06-03 | 2018-11-27 | VIP | null | null | 260011792 | RMS 2005 TRIAL |
| 260014710 | 260014782 | 1.7 | 71.7 | Palliative (P) | 2014-08-02 | 2014-08-03 | CISPLATIN + EPIRUBICIN | N | N | 260011894 | CARBOPLATIN + PACLITAXEL |
| 260014711 | 260014784 | null | 96.1 | Curative (C) | 2014-04-12 | 2014-08-16 | Vinblastine weekly | N | null | 260011916 | FLUOROURACIL |
| 260014712 | 260010092 | null | 58.85 | Curative (C) | null | 2016-02-26 | POMB | null | null | 260011937 | TEMOZOLOMIDE |
| 260014713 | 260010092 | 1.82 | 100.9 | Palliative (P) | 2016-12-01 | 2017-01-04 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260011937 | RMS 2005 TRIAL |
| 260014714 | 260010094 | 1.8 | 105.4 | Adjuvant (A) | 2017-01-12 | 2017-01-14 | CARBO + THIOTEPA + TOPOTECAN | 99 | null | 260011942 | CARBOPLATIN + ETOPOSIDE |
| 260014715 | 260010095 | 1.64 | 77 | Disease modification (D) | 2015-08-01 | 2015-08-08 | EP | 2 | N | 260012022 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014716 | 260010098 | 1.65 | 79.5 | Disease modification (D) | 2013-06-24 | 2013-06-24 | Gemcitabine + Oxaliplatin | 2 | Y | 260012037 | BLEOMYCIN |
| 260014717 | 260010098 | 1.8 | 83.7 | Curative (C) | 2015-06-08 | 2015-06-16 | Carboplatin + Etoposide IV 3 day | N | N | 260012037 | PEMBROLIZUMAB |
| 260014718 | 260010098 | 1.86 | null | null | null | 2017-11-16 | BLEOMYCIN | N | N | 260012037 | BLEOMYCIN |
| 260014719 | 260010100 | 1.54 | 76 | Disease modification (D) | 2016-12-05 | 2016-12-07 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 260012314 | AXITINIB |
| 260014720 | 260010105 | 1.86 | 97.2 | Palliative (P) | 2015-05-11 | 2015-05-15 | VeIP | 2 | N | 260012363 | CYTARABINE HD + METHOTREXATE HD |
| 260014721 | 260010106 | null | 67 | Curative (C) | 2016-05-06 | 2016-05-20 | BLEOMYCIN + VINCRISTINE | N | null | 260012532 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014722 | 260010106 | 1.82 | 102 | Neo-adjuvant (N) | 2018-06-26 | 2018-06-26 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260012532 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014723 | 260010109 | null | null | Adjuvant (A) | null | 2018-06-05 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260012567 | GEMCITABINE + OXALIPLATIN |
| 260014724 | 260010110 | 1.71 | 50 | Curative (C) | 2014-01-15 | 2014-11-04 | IFOSFAMIDE + PACLITAXEL | 2 | N | 260012648 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014725 | 260010111 | null | 78.5 | null | 2019-03-19 | 2019-03-19 | ICE | 2 | N | 260012670 | TRASTUZUMAB |
| 260014726 | 260010112 | 1.63 | 56.6 | Curative (C) | 2017-07-06 | 2017-07-07 | Pemetrexed | 2 | N | 260012721 | LIPOSOMAL DOXORUBICIN |
| 260014727 | 260010114 | 1.54 | 63 | Palliative (P) | 2018-02-14 | 2018-02-17 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260013088 | ICE |
| 260014728 | 260010115 | null | null | Disease modification (D) | null | 2017-12-21 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | null | 260013480 | DOCETAXEL + TRASTUZUMAB |
| 260014729 | 260014794 | null | 87.8 | null | null | 2018-01-17 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | null | null | 260013833 | GEMCITABINE + OXALIPLATIN |
| 260014730 | 260017099 | 1.64 | 67.5 | Palliative (P) | 2015-09-18 | 2015-09-28 | NIVOLUMAB | N | N | 260013870 | CYTARABINE HD + METHOTREXATE HD |
| 260014731 | 260010117 | 1.5 | 100 | Disease modification (D) | 2015-05-05 | 2015-05-05 | Cisplatin 7 day | 02 | null | 260014167 | CVP |
| 260014732 | 260019265 | 1.68 | 79 | Curative (C) | 2017-12-19 | 2017-12-25 | Carboplatin + Paclitaxel (3 weekly) | N | null | 260014167 | DOCETAXEL + TRASTUZUMAB |
| 260014733 | 260019265 | 1.78 | 75 | Neo-adjuvant (N) | 2014-02-16 | 2014-02-16 | NIVOLUMAB | 02 | N | 260014167 | DOCETAXEL |
| 260014734 | 260019265 | 1.68 | null | Adjuvant (A) | 2018-01-01 | 2018-01-13 | ICE | N | null | 260014167 | CVP |
| 260014735 | 260010119 | 1.55 | 97.9 | Palliative (P) | 2013-07-05 | 2013-07-07 | Docetaxel + Trastuzumab (Maint) | N | N | 260014651 | ICE |
| 260014736 | 260010121 | 1.69 | 98 | Palliative (P) | 2019-05-04 | 2019-05-08 | Carboplatin + Etoposide IV 3 day | 02 | N | 260014883 | POMB |
| 260014737 | 260010123 | 1.85 | 62 | Curative (C) | 2016-12-13 | 2017-03-14 | CARBO + THIOTEPA + TOPOTECAN | 02 | N | 260014883 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260014738 | 260010123 | 0 | 47 | Disease modification (D) | 2016-07-16 | 2016-07-23 | NIVOLUMAB | 02 | N | 260014883 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260014739 | 260010124 | 1.72 | 92.2 | Disease modification (D) | 2018-12-03 | 2018-12-16 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260014992 | VINBLASTINE |
| 260014740 | 260010124 | null | 82.8 | Palliative (P) | 2017-12-05 | 2018-02-27 | GEMCARBO | N | N | 260014992 | DACARBAZINE |
| 260014741 | 260010124 | 1.65 | 93 | Curative (C) | null | 2014-04-14 | Gemcitabine + Oxaliplatin | N | null | 260014992 | PEMETREXED |
| 260014742 | 260010125 | null | 78 | Curative (C) | 2014-07-01 | 2014-07-03 | IFOSFAMIDE + PACLITAXEL | 2 | N | 260015755 | DOCETAXEL |
| 260014743 | 260010127 | 1.76 | 69.3 | Curative (C) | 2015-08-21 | 2015-08-27 | BLEOMYCIN + VINCRISTINE | 02 | N | 260015858 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260014744 | 260010128 | null | null | Palliative (P) | 2018-11-01 | 2018-11-24 | BLEOMYCIN | N | N | 260015858 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014745 | 260010129 | null | null | Disease modification (D) | null | 2018-10-24 | VINCRISTINE | N | null | 260016002 | VINBLASTINE |
| 260014746 | 260010131 | null | 71.2 | Palliative (P) | null | 2018-11-20 | Fluorouricil + Folonic Acid (MdG) | null | N | 260016128 | CARBOPLATIN + ETOPOSIDE |
| 260014747 | 260010131 | 1.78 | 74 | Curative (C) | 2016-07-25 | 2016-08-09 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260016128 | BLEOMYCIN + VINCRISTINE |
| 260014748 | 260010132 | 1.7 | 66 | Curative (C) | 2017-07-20 | 2017-07-27 | Cisplatin 7 day | N | N | 260016215 | METHOTREXATE |
| 260014749 | 260010133 | 1.74 | 50.6 | Not known (9) | 2016-09-14 | 2016-10-07 | ESHAP | Y | null | 260016240 | CYCLOPHOSPHAMIDE |
| 260014750 | 260010134 | 1.8 | 66 | Curative (C) | 2015-03-20 | 2015-03-24 | CARBO + THIOTEPA + TOPOTECAN | 02 | N | 260016240 | BLEOMYCIN + VINCRISTINE |